{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:05:59Z","timestamp":1790525159643,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T00:00:00Z","timestamp":1414627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1208\/s12249-014-0235-3","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T22:03:55Z","timestamp":1414620235000},"page":"413-427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Protein-Functionalized PLGA Nanoparticles of Lamotrigine for Neuropathic Pain Management"],"prefix":"10.1208","volume":"16","author":[{"given":"Jigar","family":"Lalani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushilkumar","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Kolate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riddhi","family":"Lalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambikanandan","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,30]]},"reference":[{"issue":"6","key":"235_CR1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1533-2500.2008.00222.x","volume":"8","author":"MS Walid","year":"2008","unstructured":"Walid MS, Donahue SN, Darmohray DM, Hyer Jr LA, Robinson Jr JS. The fifth vital sign\u2014what does it mean? Pain Pract Off J World Inst Pain. 2008;8(6):417\u201322.","journal-title":"Pain Pract Off J World Inst Pain"},{"issue":"Suppl 2","key":"235_CR2","first-page":"S183","volume":"27","author":"B Colombo","year":"2006","unstructured":"Colombo B, Annovazzi PO, Comi G. Medications for neuropathic pain: current trends. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2006;27 Suppl 2:S183\u20139.","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"issue":"4","key":"235_CR3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1517\/13543784.12.4.545","volume":"12","author":"AN Nitu","year":"2003","unstructured":"Nitu AN, Wallihan R, Skljarevski V, Ramadan NM. Emerging trends in the pharmacotherapy of chronic pain. Expert Opin Investig Drugs. 2003;12(4):545\u201359.","journal-title":"Expert Opin Investig Drugs"},{"issue":"2 Suppl","key":"235_CR4","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","volume":"11","author":"R Benyamin","year":"2008","unstructured":"Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, et al. Opioid complications and side effects. Pain Phys. 2008;11(2 Suppl):S105\u201320.","journal-title":"Pain Phys"},{"issue":"6","key":"235_CR5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1586\/14737175.5.6.729","volume":"5","author":"E Eisenberg","year":"2005","unstructured":"Eisenberg E, Shifrin A, Krivoy N. Lamotrigine for neuropathic pain. Expert Rev Neurother. 2005;5(6):729\u201335.","journal-title":"Expert Rev Neurother"},{"issue":"9041","key":"235_CR6","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(05)66227-7","volume":"348","author":"B Sachs","year":"1996","unstructured":"Sachs B, Ronnau AC, Ruzicka T, Gleichmann E, Schuppe H-C. Lamotrigine and toxic epidermal necrolysis. Lancet. 1996;348(9041):1597.","journal-title":"Lancet"},{"issue":"1\u20133","key":"235_CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2003.09.065","volume":"482","author":"M Castel-Branco","year":"2003","unstructured":"Castel-Branco M, Lebre V, Falcao A, Figueiredo I, Caramona M. Relationship between plasma and brain levels and the anticonvulsant effect of lamotrigine in rats. Eur J Pharmacol. 2003;482(1\u20133):163\u20138.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"235_CR8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/sj.bjp.0703337","volume":"130","author":"MC Walker","year":"2000","unstructured":"Walker MC, Tong X, Perry H, Alavijeh MS, Patsalos PN. Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine. Br J Pharmacol. 2000;130(2):242\u20138.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"235_CR9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2460\/ajvr.1990.51.03.391","volume":"51","author":"W Loscher","year":"1990","unstructured":"Loscher W, Ganter M, Fassbender CP. Correlation between drug and metabolite concentrations in plasma and anesthetic action of ketamine in swine. Am J Vet Res. 1990;51(3):391\u20138.","journal-title":"Am J Vet Res"},{"issue":"6","key":"235_CR10","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/AAC.35.6.1208","volume":"35","author":"RM Fielding","year":"1991","unstructured":"Fielding RM, Smith PC, Wang LH, Porter J, Guo LS. Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats. Antimicrob Agents Chemother. 1991;35(6):1208\u201313.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"235_CR11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","volume":"3","author":"WH Jong De","year":"2008","unstructured":"De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008;3(2):133\u201349.","journal-title":"Int J Nanomedicine"},{"issue":"8","key":"235_CR12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1517\/17425240903085128","volume":"6","author":"Y Xie","year":"2009","unstructured":"Xie Y, Bagby TR, Cohen MS, Forrest ML. Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies. Expert Opin Drug Deliv. 2009;6(8):785\u201392.","journal-title":"Expert Opin Drug Deliv"},{"issue":"5","key":"235_CR13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i5.20","volume":"21","author":"I Bala","year":"2004","unstructured":"Bala I, Hariharan S, Kumar MN. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst. 2004;21(5):387\u2013422.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"1","key":"235_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","volume":"47","author":"J Kreuter","year":"2001","unstructured":"Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev. 2001;47(1):65\u201381.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"235_CR15","first-page":"252","volume":"6","author":"A Misra","year":"2003","unstructured":"Misra A, Ganesh S, Shahiwala A, Shah SP. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm. 2003;6(2):252\u201373.","journal-title":"J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm"},{"issue":"2","key":"235_CR16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.2042-7158.1996.tb07112.x","volume":"48","author":"DJ Begley","year":"1996","unstructured":"Begley DJ. The blood\u2013brain barrier: principles for targeting peptides and drugs to the central nervous system. J Pharm Pharmacol. 1996;48(2):136\u201346.","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"235_CR17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1517\/17425247.3.3.419","volume":"3","author":"Y Su","year":"2006","unstructured":"Su Y, Sinko PJ. Drug delivery across the blood\u2013brain barrier: why is it difficult? How to measure and improve it? Expert Opin Drug Deliv. 2006;3(3):419\u201335.","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"235_CR18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/10611860600650086","volume":"14","author":"MW Smith","year":"2006","unstructured":"Smith MW, Gumbleton M. Endocytosis at the blood\u2013brain barrier: from basic understanding to drug delivery strategies. J Drug Target. 2006;14(4):191\u2013214.","journal-title":"J Drug Target"},{"issue":"5990","key":"235_CR19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","volume":"312","author":"WA Jefferies","year":"1984","unstructured":"Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY. Transferrin receptor on endothelium of brain capillaries. Nature. 1984;312(5990):162\u20133.","journal-title":"Nature"},{"issue":"11","key":"235_CR20","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1074\/jbc.274.11.7011","volume":"274","author":"C Fillebeen","year":"1999","unstructured":"Fillebeen C, Descamps L, Dehouck MP, Fenart L, Benaissa M, Spik G, et al. Receptor-mediated transcytosis of lactoferrin through the blood\u2013brain barrier. J Biol Chem. 1999;274(11):7011\u20137.","journal-title":"J Biol Chem"},{"issue":"1","key":"235_CR21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2008.10.016","volume":"134","author":"K Hu","year":"2009","unstructured":"Hu K, Li J, Shen Y, Lu W, Gao X, Zhang Q, et al. Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. J Control Release Off J Control Release Soc. 2009;134(1):55\u201361.","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"6","key":"235_CR22","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.brainresbull.2009.12.008","volume":"81","author":"R Huang","year":"2010","unstructured":"Huang R, Ke W, Han L, Liu Y, Shao K, Jiang C, et al. Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo. Brain Res Bull. 2010;81(6):600\u20134.","journal-title":"Brain Res Bull"},{"issue":"1","key":"235_CR23","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","volume":"55","author":"H Fessi","year":"1989","unstructured":"Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm. 1989;55(1):R1\u20134.","journal-title":"Int J Pharm"},{"issue":"6","key":"235_CR24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1166\/jbn.2012.1462","volume":"8","author":"J Lalani","year":"2012","unstructured":"Lalani J, Raichandani Y, Mathur R, Lalan M, Chutani K, Mishra AK, et al. Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles. J Biomed Nanotechnol. 2012;8(6):918\u201327.","journal-title":"J Biomed Nanotechnol"},{"issue":"1\u20132","key":"235_CR25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijpharm.2004.10.021","volume":"289","author":"YB Huang","year":"2005","unstructured":"Huang YB, Tsai YH, Lee SH, Chang JS, Wu PC. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int J Pharm. 2005;289(1\u20132):87\u201395.","journal-title":"Int J Pharm"},{"key":"235_CR26","unstructured":"Akhnazarova S, Kafarov V. Experiment optimization in chemistry and chemical engineering. 1982."},{"issue":"4","key":"235_CR27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/00224065.1980.11980968","volume":"12","author":"G Derringer","year":"1980","unstructured":"Derringer G, Suich R. Simultaneous-optimization of several response variables. J Qual Technol. 1980;12(4):214\u20139.","journal-title":"J Qual Technol"},{"issue":"5","key":"235_CR28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/mp050032z","volume":"2","author":"SK Sahoo","year":"2005","unstructured":"Sahoo SK, Labhasetwar V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm. 2005;2(5):373\u201383.","journal-title":"Mol Pharm"},{"issue":"8","key":"235_CR29","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1023\/A:1019842024814","volume":"19","author":"JC Olivier","year":"2002","unstructured":"Olivier JC, Huertas R, Lee HJ, Calon F, Pardridge WM. Synthesis of pegylated immunonanoparticles. Pharm Res. 2002;19(8):1137\u201343.","journal-title":"Pharm Res"},{"issue":"1","key":"235_CR30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0003-2670(01)83825-3","volume":"104","author":"DP Joshi","year":"1979","unstructured":"Joshi DP, Lan-Chun-Fung YL, Pritchard JG. Determination of poly(vinyl alcohol) via its complex with boric acid and iodine. Anal Chim Acta. 1979;104(1):153\u201360.","journal-title":"Anal Chim Acta"},{"issue":"2","key":"235_CR31","first-page":"100","volume":"35","author":"A Babbar","year":"1991","unstructured":"Babbar A, Kashyap R, Chauhan UP. A convenient method for the preparation of 99mTc-labelled pentavalent DMSA and its evaluation as a tumour imaging agent. J Nucl Biol Med (Turin, Italy : 1991). 1991;35(2):100\u20134.","journal-title":"J Nucl Biol Med (Turin, Italy : 1991)"},{"key":"235_CR32","unstructured":"Theobald AE. Textbook of radiopharmacy: theory and practice. Gordon and Breach Science Publishers; 1994."},{"issue":"1","key":"235_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0883-2897(92)90179-3","volume":"19","author":"GB Saha","year":"1992","unstructured":"Saha GB, Go RT, MacIntyre WJ. Radiopharmaceuticals for cardiovascular imaging. Int J Radiat Appl Instrum B Nucl Med Biol. 1992;19(1):1\u201320.","journal-title":"Int J Radiat Appl Instrum B Nucl Med Biol"},{"issue":"4","key":"235_CR34","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0001-2998(05)80022-4","volume":"24","author":"GB Saha","year":"1994","unstructured":"Saha GB, MacIntyre WJ, Go RT. Radiopharmaceuticals for brain imaging. Semin Nucl Med. 1994;24(4):324\u201349.","journal-title":"Semin Nucl Med"},{"issue":"1\u20132","key":"235_CR35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijpharm.2004.05.025","volume":"281","author":"H Hatakeyama","year":"2004","unstructured":"Hatakeyama H, Akita H, Maruyama K, Suhara T, Harashima H. Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo. Int J Pharm. 2004;281(1\u20132):25\u201333.","journal-title":"Int J Pharm"},{"key":"235_CR36","unstructured":"ISO 10993-10:2010 Biological evaluation of medical devices\u2014part 10: tests for irritation and skin sensitization ISO. 2010."},{"issue":"3","key":"235_CR37","first-page":"85","volume":"41","author":"B Proust","year":"2009","unstructured":"Proust B, Astier C, Renaudin JM, Magueur E, Maurice D, Belcourt C, et al. A murine model of cow\u2019s milk protein-induced allergic reaction: use for safety assessment of hidden milk allergens. Eur Ann Allergy Clin Immunol. 2009;41(3):85\u201394.","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"2","key":"235_CR38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","volume":"43","author":"Z Seltzer","year":"1990","unstructured":"Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 1990;43(2):205\u201318.","journal-title":"Pain"},{"issue":"1","key":"235_CR39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","volume":"32","author":"K Hargreaves","year":"1988","unstructured":"Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32(1):77\u201388.","journal-title":"Pain"},{"issue":"1","key":"235_CR40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/2008-2231-21-58","volume":"21","author":"S Manoocheheri","year":"2013","unstructured":"Manoocheheri S, Darvishi B, Kamalinia G, Amini M, Fallah M, Ostad SN, et al. Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel. Daru J Fac Pharm Tehran Univ Med Sci. 2013;21(1):58.","journal-title":"Daru J Fac Pharm Tehran Univ Med Sci"},{"issue":"1","key":"235_CR41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0168-3659(02)00127-X","volume":"82","author":"SK Sahoo","year":"2002","unstructured":"Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release Off J Control Release Soc. 2002;82(1):105\u201314.","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"2","key":"235_CR42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","volume":"14","author":"N Desai","year":"2012","unstructured":"Desai N. Challenges in development of nanoparticle-based therapeutics. AAPS J. 2012;14(2):282\u201395.","journal-title":"AAPS J"},{"issue":"1","key":"235_CR43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1586\/17434440.1.1.115","volume":"1","author":"SS Feng","year":"2004","unstructured":"Feng SS. Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev Med Devices. 2004;1(1):115\u201325.","journal-title":"Expert Rev Med Devices"},{"key":"235_CR44","unstructured":"Gabrielsson J, Weiner D. Pharmacokinetic and pharmacodynamic data analysis: concepts and applications. CRC Press; 2001."},{"issue":"9","key":"235_CR45","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1292\/jvms.65.957","volume":"65","author":"MJ Talukder","year":"2003","unstructured":"Talukder MJ, Takeuchi T, Harada E. Receptor-mediated transport of lactoferrin into the cerebrospinal fluid via plasma in young calves. J Vet Med Sci Jpn Soc Vet Sci. 2003;65(9):957\u201364.","journal-title":"J Vet Med Sci Jpn Soc Vet Sci"},{"issue":"2","key":"235_CR46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2009.04.035","volume":"379","author":"J Chang","year":"2009","unstructured":"Chang J, Jallouli Y, Kroubi M, Yuan XB, Feng W, Kang CS, et al. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood\u2013brain barrier. Int J Pharm. 2009;379(2):285\u201392.","journal-title":"Int J Pharm"},{"issue":"1","key":"235_CR47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/exnr.1996.0178","volume":"142","author":"RD Broadwell","year":"1996","unstructured":"Broadwell RD, Baker-Cairns BJ, Friden PM, Oliver C, Villegas JC. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood\u2013brain barrier of blood-borne transferrin and antibody against the transferrin receptor. Exp Neurol. 1996;142(1):47\u201365.","journal-title":"Exp Neurol"},{"issue":"1","key":"235_CR48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1139\/o01-228","volume":"80","author":"YA Suzuki","year":"2002","unstructured":"Suzuki YA, Lonnerdal B. Characterization of mammalian receptors for lactoferrin. Biochem Cell Biol Biochim Biol Cell. 2002;80(1):75\u201380.","journal-title":"Biochem Cell Biol Biochim Biol Cell"},{"issue":"6","key":"235_CR49","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1182\/blood.V98.6.1949","volume":"98","author":"H Kawabata","year":"2001","unstructured":"Kawabata H, Germain RS, Ikezoe T, Tong X, Green EM, Gombart AF, et al. Regulation of expression of murine transferrin receptor 2. Blood. 2001;98(6):1949\u201354.","journal-title":"Blood"},{"issue":"5","key":"235_CR50","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1073\/pnas.040548097","volume":"97","author":"RE Fleming","year":"2000","unstructured":"Fleming RE, Migas MC, Holden CC, Waheed A, Britton RS, Tomatsu S, et al. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2000;97(5):2214\u20139.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-014-0235-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-014-0235-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-014-0235-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T13:59:18Z","timestamp":1717509558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-014-0235-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,30]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["235"],"URL":"https:\/\/doi.org\/10.1208\/s12249-014-0235-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,30]]}}}